Evidence map›Paper›PMID 29907634›Full record

ReviewThe British journal of ophthalmology2018

Strengthening the links between mapping, planning and global engagement for disease elimination: lessons learnt from trachoma.

Paul Courtright, Lisa A Rotondo, Chad MacArthur, Iain Jones, Angela Weaver, Biruck Kebede Negash, Nicholas Olobio, Kamal Binnawi, Simon Bush, Mariamo Abdala and 5 more

Abstract readReview
In one paragraph

Review in The British journal of ophthalmology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Trachoma.Nature reviews. Disease primers · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. The simplified trachoma grading system, amended.Bulletin of the World Health Organization · 2020
    Article
  13. Article
  14. The global burden of trichiasis in 2016.PLoS neglected tropical diseases · 2019
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Paul CourtrightKilimanjaro Centre for Community Ophthalmology, Division of Ophthalmology, University of Cape Town, Cape Town, South Africa pcourtright@kcco.net.
Lisa A RotondoRTI International, Washington, DC, USA.
Chad MacArthurKilimanjaro Centre for Community Ophthalmology, Division of Ophthalmology, University of Cape Town, Cape Town, South Africa.
Iain JonesDepartment for International Development, London, UK.
Angela WeaverUnited States Agency for International Development, Washington, DC, USA.
Biruck Kebede NegashFederal Ministry of Health, Addis Ababa, Ethiopia.
Nicholas OlobioFederal Ministry of Health, Abuja, Nigeria.
Kamal BinnawiMinistry of Health and Alneelain University, Khartoum, Sudan.
Simon BushSightsavers, Accra, Ghana.
Mariamo AbdalaNacional Eye Care Program, Ministério da Saude de Mozambique, Maputo, Mozambique.
Danny HaddadOrbis International, New York, New York, USA.
Astrid BonfieldThe Queen Elizabeth Diamond Jubilee Trust, London, UK.
Paul EmersonInternational Trachoma Initiative, Atlanta, Georgia, USA.
Virginia SarahInternational Coalition for Trachoma Control and The Fred Hollows Foundation, London, UK.
Anthony W SolomonDepartment of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundTrachoma is the leading infectious cause of blindness. Until recently, reliable data on the global extent of the disease, detailed plans for elimination, and government, donor and partner engagement were all inadequate.

methodsThe trachoma community undertook a systematic, three-pronged strategy to map trachoma district by district, develop national-level trachoma elimination plans, and create a framework for governments, donors and partners to convene and coordinate in support of trachoma elimination. 

resultThere has been a frame-shift in internal and external perceptions of the global trachoma programme, from being an effort working towards disease control in focussed geographical areas, to one in the process of achieving worldwide disease elimination. Multiple factors contributed to the successful implementation of mapping, planning, and cross-sectional engagement of governments, partners and donors.

conclusionsElimination of trachoma is possible if the right combination of factors is in place. Planning for success is a critical first step. Some remaining challenges must still be addressed if the elimination targets are to be successfully attained.

Indexed as

Eye Infections, BacterialTrachomaBlindnessDisease EradicationGlobal HealthHumansPrevalenceRisk FactorsEpidemiologyPublic health

Identifiers

PMID29907634
PMCPMC6173819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.